Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Radford-Smith

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Gastroenterology and Hepatology|March 21, 2002
Chronic narcotic use in inflammatory bowel disease patients: prevalence and clinical characteristicsJ T Edwards, G L Radford-Smith, T H Florin
Gut|June 15, 2004
Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseasesT H J Florin, N Pandeya, G L Radford-Smith
Internal Medicine Journal|August 2, 2001
Early Australian experience with infliximab, a chimeric antibody against tumour necrosis factor-alpha, in the treatment of Crohn's disease: is its efficacy augmented by steroid-sparing immunosuppressive therapy? The Infliximab User GroupM Mortimore, P R Gibson, W S Selby, et al.
Gut|February 29, 2008
Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's diseaseL A Simms, J D Doecke, M D Walsh, et al.
Journal of Medical Genetics|June 7, 2005
TNFalpha and IL10 SNPs act together to predict disease behaviour in Crohn's diseaseE V Fowler, R Eri, G Hume, et al.
Journal of Medical Genetics|October 19, 2006
Angiotensinogen and transforming growth factor beta1: novel genes in the pathogenesis of Crohn's diseaseG E Hume, E V Fowler, D Lincoln, et al.
Gut|November 13, 2002
Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's diseaseG L Radford-Smith, J E Edwards, D M Purdie, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|August 2, 2012
Surgical outcomes in steroid refractory acute severe ulcerative colitis: the impact of rescue therapyM P Powar, P Martin, A R Croft, et al.
Genes and Immunity|June 25, 2004
CCR5-Delta32 mutation is strongly associated with primary sclerosing cholangitisR Eri, J R Jonsson, N Pandeya, et al.
The Journal of Pathology|November 30, 2005
Characterization of tumour-infiltrating lymphocytes and apoptosis in colitis-associated neoplasia: comparison with sporadic colorectal cancerJ M Michael-Robinson, N Pandeya, M D Walsh, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Gastroenterology and Hepatology|March 21, 2002
Chronic narcotic use in inflammatory bowel disease patients: prevalence and clinical characteristicsJ T Edwards, G L Radford-Smith, T H Florin
Gut|June 15, 2004
Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseasesT H J Florin, N Pandeya, G L Radford-Smith
Internal Medicine Journal|August 2, 2001
Early Australian experience with infliximab, a chimeric antibody against tumour necrosis factor-alpha, in the treatment of Crohn's disease: is its efficacy augmented by steroid-sparing immunosuppressive therapy? The Infliximab User GroupM Mortimore, P R Gibson, W S Selby, et al.
Gut|February 29, 2008
Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's diseaseL A Simms, J D Doecke, M D Walsh, et al.
Journal of Medical Genetics|June 7, 2005
TNFalpha and IL10 SNPs act together to predict disease behaviour in Crohn's diseaseE V Fowler, R Eri, G Hume, et al.
Journal of Medical Genetics|October 19, 2006
Angiotensinogen and transforming growth factor beta1: novel genes in the pathogenesis of Crohn's diseaseG E Hume, E V Fowler, D Lincoln, et al.
Gut|November 13, 2002
Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's diseaseG L Radford-Smith, J E Edwards, D M Purdie, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|August 2, 2012
Surgical outcomes in steroid refractory acute severe ulcerative colitis: the impact of rescue therapyM P Powar, P Martin, A R Croft, et al.
Genes and Immunity|June 25, 2004
CCR5-Delta32 mutation is strongly associated with primary sclerosing cholangitisR Eri, J R Jonsson, N Pandeya, et al.
The Journal of Pathology|November 30, 2005
Characterization of tumour-infiltrating lymphocytes and apoptosis in colitis-associated neoplasia: comparison with sporadic colorectal cancerJ M Michael-Robinson, N Pandeya, M D Walsh, et al.
Pageof 2